Squarepoint’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-59,070
| Closed | -$408K | – | 3334 |
|
|
2025
Q1 | $408K | Sell |
59,070
-45,564
| -44% | -$314K | ﹤0.01% | 2027 |
|
|
2024
Q4 | $555K | Buy |
+104,634
| New | +$555K | ﹤0.01% | 1881 |
|
|
2024
Q2 | – | Sell |
-36,461
| Closed | -$127K | – | 3092 |
|
|
2024
Q1 | $127K | Sell |
36,461
-25,438
| -41% | -$88.5K | ﹤0.01% | 2207 |
|
|
2023
Q4 | $88.5K | Buy |
61,899
+3,632
| +6% | +$5.19K | ﹤0.01% | 2291 |
|
|
2023
Q3 | $85.1K | Buy |
58,267
+19,191
| +49% | +$28K | ﹤0.01% | 2277 |
|
|
2023
Q2 | $61.3K | Buy |
39,076
+21,093
| +117% | +$33.1K | ﹤0.01% | 2274 |
|
|
2023
Q1 | $27.5K | Buy |
+17,983
| New | +$27.5K | ﹤0.01% | 2159 |
|
|
2022
Q3 | – | Sell |
-27,432
| Closed | -$46K | – | 2615 |
|
|
2022
Q2 | $46K | Buy |
+27,432
| New | +$46K | ﹤0.01% | 1965 |
|
|
2022
Q1 | – | Sell |
-13,947
| Closed | -$52K | – | 2925 |
|
|
2021
Q4 | $52K | Buy |
+13,947
| New | +$52K | ﹤0.01% | 2404 |
|
|
2021
Q3 | – | Sell |
-33,581
| Closed | -$331K | – | 2840 |
|
|
2021
Q2 | $331K | Buy |
33,581
+17,981
| +115% | +$177K | ﹤0.01% | 1899 |
|
|
2021
Q1 | $146K | Sell |
15,600
-13,877
| -47% | -$130K | ﹤0.01% | 2261 |
|
|
2020
Q4 | $141K | Sell |
29,477
-8,263
| -22% | -$39.5K | ﹤0.01% | 2255 |
|
|
2020
Q3 | $151K | Buy |
+37,740
| New | +$151K | ﹤0.01% | 2035 |
|
|
2018
Q2 | – | Sell |
-55,450
| Closed | -$233K | – | 2100 |
|
|
2018
Q1 | $233K | Buy |
+55,450
| New | +$233K | ﹤0.01% | 1425 |
|
|
2017
Q4 | – | Sell |
-30,000
| Closed | -$129K | – | 2372 |
|
|
2017
Q3 | $129K | Buy |
30,000
+6,639
| +28% | +$28.5K | ﹤0.01% | 1466 |
|
|
2017
Q2 | $89K | Buy |
+23,361
| New | +$89K | ﹤0.01% | 1410 |
|